Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
ARS Pharmaceuticals (SPRY)
NASDAQ:SPRY
Holding SPRY?
Track your performance easily
ARS Pharmaceuticals (SPRY) Ownership Overview
61.32% Insiders
7.88% Mutual Funds
2.40% Other Institutional Investors
7.68% ETFs
20.72% Public Companies and
Individual Investors
The ownership structure of ARS Pharmaceuticals (SPRY) stock is a mix of institutional, retail, and individual investors. Approximately 17.95% of the company’s stock is owned by Institutional Investors, 61.32% is owned by Insiders, and 20.72% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Aug 28, 2024 | Peter A. Thompson Director | xxxxxxxxxxxxx | $1088035 |
| Aug 28, 2024 | Orbimed Advisors Llc Director | xxxxxxxxxxxxx | $1088035 |
| Aug 23, 2024 | Peter A. Thompson Director | xxxxxxxxxxxxx | $11497963 |
| Aug 23, 2024 | Orbimed Advisors Llc Director | xxxxxxxxxxxxx | $11497963 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Jun 30, 2024 | xxxxxxxxxxxxx | $2392535 | |
| Jun 30, 2024 | xxxxxxxxxxxxx | $5494907 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 11,765,600 | Insider | 12.14% | 205,780,344 | |
| 11,765,600 | Insider | 12.14% | 205,780,344 | |
| 11,077,927 | Institution | 11.43% | 193,752,943 | |
| 10,860,977 | Insider | 11.20% | 189,958,488 | |
| 10,860,977 | Institution | 11.20% | 189,958,488 | |
| 8,288,510 | Insider | 8.55% | 144,966,040 | |
| 8,288,510 | Insider | 8.55% | 144,966,040 | |
| 4,824,554 | Insider | 4.98% | 84,381,449 | |
| 3,142,932 | Institution | 3.24% | 54,969,881 | |
| 3,009,677 | Insider | 3.10% | 52,639,251 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 2,666,061 | Institution | 2.75% | 46,629,407 | |
| 1,082,956 | Institution | 1.12% | 18,940,900 | |
| 1,020,789 | Institution | 1.05% | 17,853,600 | |
| 578,961 | Institution | 0.60% | 10,126,028 | |
| 550,323 | Institution | 0.57% | 9,625,149 | |
| 420,124 | Institution | 0.43% | 7,347,969 | |
| 250,401 | Institution | 0.26% | 4,379,513 | |
| 227,789 | Institution | 0.23% | 3,984,030 | |
| 140,937 | Institution | 0.15% | 2,464,988 | |
| 120,900 | Institution | 0.12% | 2,114,541 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,863,226 | Institution | 1.92% | 27,016,777 | |
| 1,354,856 | Institution | 1.40% | 23,696,431 | |
| 913,536 | Institution | 0.94% | 15,566,653 | |
| 824,496 | Institution | 0.85% | 11,955,192 | |
| 442,493 | Institution | 0.46% | 7,739,203 | |
| 342,643 | Institution | 0.35% | 5,992,826 | |
| 251,050 | Institution | 0.26% | 4,277,892 | |
| 225,286 | Institution | 0.23% | 3,266,647 | |
| 112,349 | Institution | 0.12% | 1,964,984 | |
| 129,244 | Institution | 0.13% | 1,874,038 |
FAQ
Who Owns ARS Pharmaceuticals (SPRY)?
According to the latest TipRanks data, approximately 2.40% of the company's stock is held by institutional investors, 61.32% is held by insiders, and 20.72% is held by retail investors.
What percentage of ARS Pharmaceuticals (SPRY) stock is held by institutional investors?
According to the latest TipRanks data, approximately 2.40% of ARS Pharmaceuticals (SPRY) stock is held by institutional investors.
What percentage of ARS Pharmaceuticals (SPRY) stock is held by retail investors?
According to the latest TipRanks data, approximately 20.72% of ARS Pharmaceuticals (SPRY) stock is held by retail investors.
Who owns the most shares of ARS Pharmaceuticals (SPRY)?
Sarina Tanimoto owns the most shares of ARS Pharmaceuticals (SPRY).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.